1800-272-662
Shopping Cart 0
countryflagAU
Login

Vitura Health Ltd

Healthcare AU VIT

0.04AUD
-0.001(2.44%)

Last update at 2026-03-13T04:47:00Z

Day Range

0.040.04
LowHigh

52 Week Range

0.040.08
LowHigh

Fundamentals

  • Previous Close 0.04
  • Market Cap27.84M
  • Volume386955
  • P/E Ratio-
  • Dividend Yield4.88%
  • EBITDA1.93M
  • Revenue TTM129.24M
  • Revenue Per Share TTM0.20
  • Gross Profit TTM 32.32M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 4.71M 4.56M 20.05M 9.74M -4.20585M
Minority interest 0.26M 0.26M 0.06M 0.04M 0.16M
Net income 3.32M 3.51M 13.81M 6.05M -4.04921M
Selling general administrative 8.96M 17.56M 14.37M 14.13M 4.21M
Selling and marketing expenses 1.91M 2.77M 0.54M 0.53M 0.29M
Gross profit 33.75M 34.22M 25.96M 25.43M 0.87M
Reconciled depreciation 2.28M 1.64M 0.99M 0.68M 3.43M
Ebit 5.24M 5.43M 19.86M 10.19M -3.91169M
Ebitda 5.64M 7.08M 20.85M 10.87M -0.48662M
Depreciation and amortization 0.40M 1.64M 0.99M 0.68M 3.43M
Non operating income net other - - - - -
Operating income 5.24M 4.87M 19.86M 10.19M -3.91169M
Other operating expenses 118.80M 119.00M 97.48M 57.75M 9.16M
Interest expense 1.33M 1.05M 0.03M 0.44M 0.29M
Tax provision 1.64M 1.31M 6.30M 3.73M 0.47M
Interest income 0.43M 0.67M 0.33M 0.00907M 0.05M
Net interest income -0.82011M -0.37746M 0.11M -0.43237M -0.24760M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 1.64M 1.31M 6.30M 3.73M 0.22M
Total revenue 124.04M 123.87M 117.34M 66.99M 1.69M
Total operating expenses 28.51M 29.35M 6.09M 16.19M 8.34M
Cost of revenue 90.29M 89.65M 91.39M 41.56M 0.82M
Total other income expense net -0.53643M -0.30286M 0.19M 0.25M 0.08M
Discontinued operations - - - - -
Net income from continuing ops 3.06M 3.25M 13.75M 6.01M -4.20585M
Net income applicable to common shares 3.32M 3.51M 13.81M 6.05M 1.42M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 75.49M 71.28M 46.90M 42.87M 12.69M
Intangible assets 18.05M - 7.10M 0.33M 0.20M
Earning assets - - - - -
Other current assets 2.19M 0.88M 0.19M 0.04M 0.47M
Total liab 27.89M 32.84M 11.92M 16.79M 3.47M
Total stockholder equity 48.20M 38.78M 34.98M 26.10M 9.30M
Deferred long term liab - - - - -
Other current liab 5.11M 10.60M 0.84M 5.81M 0.61M
Common stock 36.93M 30.79M 24.04M 22.78M 20.01M
Capital stock - - 24.04M 22.78M 20.01M
Retained earnings 16.00M 12.67M 14.74M 6.47M -10.83327M
Other liab - - 0.08M 0.05M 0.01M
Good will 22.20M 18.52M 6.83M 6.83M 0.29M
Other assets - - 1.38M 2.54M 0.21M
Cash 7.58M 11.35M 18.85M 16.08M 9.47M
Cash and equivalents - - - - -
Total current liabilities 18.84M 23.36M 10.87M 12.17M 3.21M
Current deferred revenue - 0.00722M - - -
Net debt 4.39M -0.32607M - -11.01744M -7.10327M
Short term debt 3.12M 1.73M 0.00000M 0.49M 2.11M
Short long term debt - - - - 2.01M
Short long term debt total 11.97M 11.02M - 5.06M 2.36M
Other stockholder equity - - -3.80305M -3.14862M -0.14082M
Property plant equipment - - 2.41M 5.58M 0.91M
Total current assets 25.72M 30.97M 36.00M 27.59M 11.76M
Long term investments - - 0.37M 0.60M -
Net tangible assets - - 27.88M 18.94M 3.81M
Short term investments - - - - -
Net receivables 9.97M 13.74M 9.34M 5.76M 0.43M
Long term debt - - - - -
Inventory 5.98M 5.01M 6.91M 5.03M 1.34M
Accounts payable 10.61M 11.03M 6.92M 5.87M 0.50M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -4.72891M -4.67807M - -3.14862M 0.12M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 2.49M 0.77M - - -
Deferred long term asset charges - - - - -
Non current assets total 49.78M 40.31M 10.89M 15.28M 0.93M
Capital lease obligations - - 1.28M 5.06M 0.35M
Long term debt total - - 1.04M 4.57M 0.54M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -13.86770M -13.20345M -0.83772M 2.00M -0.16068M
Change to liabilities - - 0.29M 6.19M 2.62M
Total cashflows from investing activities -13.86770M -13.20345M -0.83772M 2.00M -0.47936M
Net borrowings 3.89M 5.35M -0.63558M -0.31811M -0.37965M
Total cash from financing activities 7.43M -1.29511M -6.09859M -1.50365M -0.26203M
Change to operating activities - - 0.06M -0.21022M -0.02075M
Net income 3.32M 3.51M 13.81M 6.05M 1.42M
Change in cash -3.76879M -7.50116M 2.77M 14.00M -5.21877M
Begin period cash flow 11.35M 18.85M 16.08M 2.08M 14.69M
End period cash flow 7.58M 11.35M 18.85M 16.08M 9.47M
Total cash from operating activities 2.67M 7.00M 9.71M 13.50M 1.07M
Issuance of capital stock 5.17M 0.41M - - -
Depreciation 2.28M 1.64M 0.99M 0.68M 0.21M
Other cashflows from investing activities -7.53418M -0.75999M 0.08M 2.37M -0.22000M
Dividends paid 0.00000M -5.43832M -5.46301M 1.50M 0.34M
Change to inventory -0.96714M 1.90M -1.87892M -1.92881M -1.86456M
Change to account receivables -1.73400M -3.30662M -3.57603M -3.57964M -1.76879M
Sale purchase of stock -0.02577M -0.04941M - -1.18554M -0.17189M
Other cashflows from financing activities -0.02577M -1.56238M -0.63558M 2.69M -0.05732M
Change to netincome - - 0.01M 6.30M 0.48M
Capital expenditures 0.08M 0.79M 0.93M 0.38M 0.06M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -2.63011M -1.13514M -5.10282M 0.47M -1.03111M
Stock based compensation 0.03M 0.04M 0.75M 2.53M 0.03M
Other non cash items -0.34187M 2.94M 7.15M 6.99M 1.90M
Free cash flow 2.58M 6.21M 8.78M 13.13M 1.01M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
VIT
Vitura Health Ltd		 -0.001 2.44% 0.04 - - 0.22 0.59 0.28 6.93
AFP
Aft Pharmaceuticals Ltd		 - -% 3.00 23.08 19.88 1.35 3.81 1.72 13.67
VLS
Vita Life Sciences Ltd		 -0.02 0.80% 2.48 13.89 42.73 1.46 2.42 1.24 6.53
SNT
Syntara Ltd		 -0.001 3.33% 0.03 - 20.45 6.32 4.62 6.32 -2.1607
MVP
Medical Developments International Ltd		 0.005 1.23% 0.41 - 166.67 1.14 0.83 0.75 11.48

Reports Covered

Stock Research & News

View All

Profile

Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia. It operates through two segments: Sales and Distribution; and Clinics and Services. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for alternative therapies; Doctors on Demand, a premier provider of on-demand virtual healthcare services; BHC, an alternative therapy distributor; CDA Clinics, which provides medicinal consultations and prescription services; and Cannadoc, a therapy clinic that offers telehealth consultations. It also offers psychedelics under the Cortexa brand; Adaya which provides hybrid formulations and Australian-cultivated products; candor medical that provides care to patients; and inscape, which offers crafted formulations for individual needs. The company was formerly known as Cronos Australia Limited and changed its name to Vitura Health Limited in February 2023. Vitura Health Limited was incorporated in 2018 and is based in South Yarra, Australia.

Vitura Health Ltd

Suite 8, Level 3, South Yarra, VIC, Australia, 3141

Key Executives

Name Title Year Born
Mr. Rodney Damon Cocks CEO & Executive Director NA
Mr. Thomas Godfrey Howitt ACIS, AICPA, B.Com., C.A, FTIA CFO & Company Secretary 1964
Mr. Guy Rothwell Headley Chief Commercial Officer & Executive Director NA
Mr. Ryan J. Tattle Chief Revenue Officer NA
Ms. Kirsty Garrett Chief Operating Officer NA
Mr. Jeffrey Lerner Head of Technology NA
Ms. Natalie Khoury Head of Customer Experience NA
Mr. Ben Cirillo Financial Controller NA
Mr. Rodney Damon Cocks CEO & Executive Director NA
Mr. Thomas Godfrey Howitt ACIS, AICPA, B.Com., C.A, FTIA CFO & Company Secretary 1964

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.